New York City Injury Cases: Fosamax

Fosamax and Other Dangerous Drugs in NYC

Fosamax, a drug that has been promoted by Merck & Co. for the treatment of osteoporosis, has been found to have some very serious side effects in certain cases. These side effects include a bone condition that is called osteonecrosis, ONJ, or also often termed "dead jaw". This condition is extremely dangerous and disfiguring, and in cases in which the individual suffering from the condition was prescribed Fosamax, the case should be reviewed at once by a New York City personal injury attorney from Hecht, Kleeger & Damashek. Our legal team is aggressive in pursuing compensation and justice for our clients who have suffered this debilitating and dangerous condition.

Fosamax: Civil Claims Against Merck & Co.

There are a number of claims that have been filed against the manufacturer of Fosamax. We are here to protect the rights of our clients who have been the victim of this disease and were taking the drug prior to the condition developing. The disease of ONJ is very difficult to treat or resolve, and will be expensive and likely require ongoing treatment to try to cure or bring to a halt. As the disease, also termed aseptic necrosis of the mandible or maxilla, jaw death, or dead jaw disease, causes a condition in which the jaw area begins to become infected and then rot, often causing severe and permanent disfigurement and other serious health dangers.

The disease usually starts after an injury to the jaw, such as dental work or a tooth extraction. As time passes, the area affected will not heal, and infection begins to spread to other areas of the jaw. This condition is dangerous, and if you or a loved one has been using Fosamax and now is suffering a serious side effect, or has lost their life through the use of this potentially dangerous drug, it is necessary to seek the highest quality, experienced legal representation.

Contact a New York City dangerous drug attorney if you or a loved one has suffered injury through the use of the drug Fosamax.